Chemomab Therapeutics (CMMB) Investor Presentation - Slideshow

Pioneering Innovative Treatments for Fibrotic Diseases Corporate Overview | Nasdaq: CMMB | Non-Confidential | June 2022 Forward Looking Statements This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act. These forward-looking statements include, among other things, statements regarding the clinical development pathway for CM-101; the future operations of Chemomab and its ability to successfully initiate and complete clinical trials and achie ...